亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

上海市柏際醫藥有限公司  

輪環藤寧等雜環類,胡椒環系類

搜索
新聞分類
  • 暫無分類
聯系方式
  • 聯系人:周女士
  • 電話:0513-89066587
  • 郵件:sales01@biogenepharm.com
  • QQ:1930575102
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 公司新聞 > 極具開發前景的甲氧胺***
公司新聞
極具開發前景的甲氧胺***
2014-12-22IP屬地 火星56
 甲氧胺***,也稱***甲氧胺,O-甲基羥胺***,英文名O-Methylhydroxylamine-hydrochloride,CAS登錄號593-56-6,分子式CH3ONH2•HCI,分子量83.5。 
本品為白色晶體粉末,熔點149~152℃,易溶于水,溶于醇,不溶于**及***等,溶液呈酸性。 
    甲氧胺***是重要的中間體,廣泛應用于功能染料、低毒農藥、新型除草劑及醫藥的合成。在醫藥方面主要用于生產頭孢呋辛,農藥方面主要用于生產苯氧菌酯等

 

臺州保隆化工有限公司 已量化生產 歡迎廠家詢問!
Amanda 0576-88702853



中文別名: 甲氧基胺***;O-甲基羥胺***
英文名稱: Methoxyamine hydrochloride
英文別名: O-Methylhydroxylamine hydrochloride;Methoxylamine hydrochloride
CAS號: 593-56-6
分子式: CH5NO.HCl

©2025 上海市柏際醫藥有限公司 版權所有   技術支持:化工網   訪問量:3882  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |